↓ Skip to main content

Dove Medical Press

Current and emerging drugs for the treatment of inflammatory bowel disease

Overview of attention for article published in Drug Design, Development and Therapy, April 2011
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#9 of 2,268)
  • High Attention Score compared to outputs of the same age (99th percentile)
  • Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news
46 news outlets
twitter
1 X user
patent
15 patents

Citations

dimensions_citation
230 Dimensions

Readers on

mendeley
371 Mendeley
Title
Current and emerging drugs for the treatment of inflammatory bowel disease
Published in
Drug Design, Development and Therapy, April 2011
DOI 10.2147/dddt.s11290
Pubmed ID
Authors

John K Triantafillidis, Emmanuel Merikas, Filippos Georgopoulos

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 371 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Uganda 1 <1%
South Africa 1 <1%
Czechia 1 <1%
Singapore 1 <1%
United States 1 <1%
Philippines 1 <1%
Unknown 365 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 58 16%
Student > Ph. D. Student 52 14%
Student > Bachelor 48 13%
Researcher 45 12%
Other 29 8%
Other 63 17%
Unknown 76 20%
Readers by discipline Count As %
Medicine and Dentistry 74 20%
Agricultural and Biological Sciences 58 16%
Biochemistry, Genetics and Molecular Biology 33 9%
Pharmacology, Toxicology and Pharmaceutical Science 27 7%
Chemistry 17 5%
Other 62 17%
Unknown 100 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 364. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 January 2024.
All research outputs
#87,365
of 25,374,647 outputs
Outputs from Drug Design, Development and Therapy
#9
of 2,268 outputs
Outputs of similar age
#226
of 120,716 outputs
Outputs of similar age from Drug Design, Development and Therapy
#2
of 9 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 120,716 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.